MASI Learn · Healthy aging systems
Metabolism and metabolic longevity
The practical answer: preserve muscle, maintain cardiorespiratory fitness, eat a high-quality diet you can sustain, sleep consistently, and treat blood pressure, lipids, and glucose abnormalities with appropriate clinical care. MASI NMN can complement this program as an NAD+ precursor; resveratrol adds a polyphenol lane. Neither is a diabetes medicine or a substitute for prescribed metabolic treatment.
Metabolic health is a system, not a single number
Useful assessment combines waist or body-composition trends, blood pressure, fasting glucose or HbA1c when indicated, lipids, liver health, fitness, strength, sleep, and family history. A normal weight does not guarantee low metabolic risk, and weight loss alone does not show whether muscle was preserved.
Resistance training helps maintain muscle, which is a major site of glucose disposal. Aerobic training improves cardiorespiratory capacity and can reduce cardiometabolic risk. Protein and energy intake should support lean mass, particularly during intentional weight loss. Persistent thirst, frequent urination, unexplained weight change, or abnormal laboratory results needs clinical assessment.
What NMN human trials show
NMN is a precursor in NAD+ metabolism. In human trials, oral NMN has increased blood NAD-related measures, but effects on glucose regulation, performance, and body composition vary by population and endpoint.
In a randomized trial in postmenopausal women with prediabetes, NMN increased skeletal-muscle insulin sensitivity and altered muscle signalling, while other systemic outcomes were not uniformly changed. This is an important physiological finding, not evidence that NMN treats diabetes. Read the trial.
A randomized dose-ranging study in healthy middle-aged adults assessed 300, 600, and 900 mg daily for 60 days and reported dose-related changes in blood NAD measures alongside safety and selected functional endpoints. The study supports oral bioactivity but does not establish one universal dose or long-term disease prevention. Read the trial.
Resveratrol trials examine diverse metabolic and vascular outcomes, with results shaped by dose, formulation, population, and duration. A positive endpoint in one group should not be generalized to every customer. Review a long-term human trial.
Choosing a MASI metabolic-longevity program
Best first choice for NAD+ support: MASI NMN. It suits customers seeking a clearly defined cellular-energy pathway within an exercise- and nutrition-led program. Follow the label, keep prescriptions unchanged, and learn more at NMN and NAD+ biology.
Best polyphenol addition: MASI Resveratrol. It adds a distinct polyphenol research lane and may suit a broader cardiovascular or healthy-aging interest. It should not be marketed as glucose-lowering therapy. Review medicine interactions first.
For a broader longevity stack: spermidine or fisetin may be considered for separate autophagy or senescence research interests, but they do not become metabolic drugs when combined. Start with one product, define its role, and add only after tolerability is clear.
A practical 90-day plan combines resistance training, aerobic work, a stable nutrition pattern, and one core MASI product. Track waist trend, training performance, sleep, and clinician-ordered laboratory markers where appropriate. Do not use home readings to change prescriptions without medical guidance.
If you use GLP-1 or other prescription metabolic care
Continue the plan agreed with your prescriber. During appetite suppression or weight loss, prioritize adequate protein, hydration, resistance training, and monitoring for adverse effects. MASI supplements are optional nutritional layers, not alternatives to semaglutide, tirzepatide, metformin, insulin, or other medicines. See the GLP-1 support education hub for a practical, non-substitute approach.
Frequently asked questions
Can NMN lower my blood sugar?
NMN has been studied in metabolic endpoints, including a trial showing improved muscle insulin sensitivity in a specific group of women with prediabetes. That does not make NMN a glucose-lowering medicine. If glucose is elevated, use clinician-directed testing and treatment.
Which MASI product should I start with?
NMN is the clearest first choice for an NAD+ precursor program. Resveratrol can be added when a polyphenol lane fits the goal and medicine review is complete. Starting sequentially makes adherence and tolerability easier to interpret.
Can I use MASI products while taking a GLP-1 medicine?
Potential use depends on the product, your symptoms, nutrition intake, medical conditions, and other medicines. MASI products do not replace GLP-1 therapy. Ask the prescriber or pharmacist to review the exact labels, especially if nausea, dehydration, gallbladder symptoms, or low food intake is present.
What should I measure over 90 days?
Use outcomes tied to health: training consistency, strength, waist trend, blood pressure, sleep, and clinician-ordered glucose or lipid markers. Scale weight alone cannot show whether muscle was preserved. Do not intensify treatment based on a supplement experiment without clinical guidance.
Build a 90-day MASI program or browse MASI Learn.